At present, several oral antidiabetic medications are used for the treatment of T2DM including, -glucosidases inhibitors, biguanides, sulfonylureas, meglitinides, GLP-1 receptor agonists (GLP-1RAs), peroxisome proliferator-activated receptor (PPAR-) agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and sodiumglucose transporter 2 (SGLT2) inhibitors
the daily dosages used in women are much lower than for products used in males
Individual results may vary based on body area and metabolism
As more providers enter the market, understanding the options available becomes increasingly important
Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Neurosciences 2021;8:70-80
Middle East Market Insight : High interest in beauty-from-within and liver health supplements supports market expansion